NCT06313047Completed
Pharmacogenetic of Doxorubicin in HCC.
Pharmacogenetic of Doxorubicin in Patients With Hepatocellular Carcinoma: A Prospective Cohort Study
Source: ClinicalTrials.gov · Last updated 28 Mar 2024
Brief summary (registry, in English)
The study included 81 HCC patients, both male and female. Prior to being assessed for eligibility, each recruited patient with HCC received a comprehensive review of their medical history, physical status, and laboratory results. Every research participant take part in the experiment and provided written informed consent.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 81 (actual)
- First submitted
- 9 Mar 2024
- Start date
- 1 Jan 2021
- Primary completion date
- 15 Dec 2023
- Lead sponsor
- Rehab Werida
- Diseases
- Liver and biliary tract cancer
- NCT number
- NCT06313047
What you commit to
- Study type: Observational
- Participants enrolled: 81
- From 1 Jan 2021 to the primary completion date, 15 Dec 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- There is a notable case of portal vein thrombosis.
Age
- Be more than 75 years old.
Other
- The patients refused to sign the formal consent.
- Spreads beyond the liver.
- Encephalopathy of the liver.
- Present sickness.
Who the study is looking for
- When diagnosing the patient with HCC, the guidelines provided by the American Association for the Study of Liver Diseases (AASLD) were adhered to.
- Be above 20 years old.
- Individuals with intact organs.
- There is no cure for HCC in surgery, microwave treatment, or radiofrequency ablation.
Age in the registry: 20 years to 75 years · Sex: All
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| King Abdullah bin Abdulaziz University Hospital Coordinator of this site? Confirm its status | Riyadh | Saudi Arabia | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.